Trajectories of comorbidities in patients with psoriasis: a question to be answered
- PMID: 36680335
- DOI: 10.1093/bjd/ljac126
Trajectories of comorbidities in patients with psoriasis: a question to be answered
Conflict of interest statement
Conflicts of interest P.C. has received consulting fees from AbbVie, Amgen, Pfizer, Roche Chugai, BMS, MSD, UCB, Novartis, Janssen, Lilly, Galapagos and Celgene (< $10 000 each) and has been an investigator for Roche Chugai, Sanofi Aventis, Celgene, Pfizer, MSD, Novartis and BMS.
Comment on
-
Exploring disease comorbidities and temporal disease progression of psoriasis: an observational, retrospective, multi-database, cohort study.Br J Dermatol. 2023 Feb 22;188(3):372-379. doi: 10.1093/bjd/ljac086. Br J Dermatol. 2023. PMID: 36637104
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
